Dow Earnings Calls
| Release date | Apr 23, 2026 |
| EPS estimate | -$0.390 |
| EPS actual | -$0.140 |
| EPS Surprise | 64.10% |
| Revenue estimate | 9.656B |
| Revenue actual | 9.794B |
| Revenue Surprise | 1.43% |
| Release date | Jan 29, 2026 |
| EPS estimate | -$0.464 |
| EPS actual | -$0.340 |
| EPS Surprise | 26.66% |
| Revenue estimate | 9.462B |
| Revenue actual | 9.46B |
| Revenue Surprise | -0.0225% |
| Release date | Oct 23, 2025 |
| EPS estimate | -$0.308 |
| EPS actual | -$0.190 |
| EPS Surprise | 38.41% |
| Revenue estimate | 10.22B |
| Revenue actual | 9.973B |
| Revenue Surprise | -2.42% |
| Release date | Jul 24, 2025 |
| EPS estimate | -$0.173 |
| EPS actual | -$0.420 |
| EPS Surprise | -142.12% |
| Revenue estimate | 10.244B |
| Revenue actual | 10.104B |
| Revenue Surprise | -1.36% |
Last 4 Quarters for Dow
Below you can see how DOW performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 24, 2025 |
| Price on release | $25.07 |
| EPS estimate | -$0.173 |
| EPS actual | -$0.420 |
| EPS surprise | -142.12% |
| Date | Price |
|---|---|
| Jul 18, 2025 | $28.34 |
| Jul 21, 2025 | $28.39 |
| Jul 22, 2025 | $29.66 |
| Jul 23, 2025 | $30.37 |
| Jul 24, 2025 | $25.07 |
| Jul 25, 2025 | $25.51 |
| Jul 28, 2025 | $25.71 |
| Jul 29, 2025 | $25.18 |
| Jul 30, 2025 | $23.92 |
| 4 days before | -11.54% |
| 4 days after | -4.59% |
| On release day | 1.76% |
| Change in period | -15.60% |
| Release date | Oct 23, 2025 |
| Price on release | $24.51 |
| EPS estimate | -$0.308 |
| EPS actual | -$0.190 |
| EPS surprise | 38.41% |
| Date | Price |
|---|---|
| Oct 17, 2025 | $21.89 |
| Oct 20, 2025 | $21.63 |
| Oct 21, 2025 | $21.75 |
| Oct 22, 2025 | $21.70 |
| Oct 23, 2025 | $24.51 |
| Oct 24, 2025 | $24.81 |
| Oct 27, 2025 | $25.73 |
| Oct 28, 2025 | $25.38 |
| Oct 29, 2025 | $24.86 |
| 4 days before | 11.97% |
| 4 days after | 1.43% |
| On release day | 1.22% |
| Change in period | 13.57% |
| Release date | Jan 29, 2026 |
| Price on release | $27.16 |
| EPS estimate | -$0.464 |
| EPS actual | -$0.340 |
| EPS surprise | 26.66% |
| Date | Price |
|---|---|
| Jan 23, 2026 | $28.25 |
| Jan 26, 2026 | $28.18 |
| Jan 27, 2026 | $27.81 |
| Jan 28, 2026 | $27.78 |
| Jan 29, 2026 | $27.16 |
| Jan 30, 2026 | $27.55 |
| Feb 02, 2026 | $28.88 |
| Feb 03, 2026 | $30.49 |
| Feb 04, 2026 | $32.40 |
| 4 days before | -3.86% |
| 4 days after | 19.29% |
| On release day | 1.44% |
| Change in period | 14.69% |
| Release date | Apr 23, 2026 |
| Price on release | $38.53 |
| EPS estimate | -$0.390 |
| EPS actual | -$0.140 |
| EPS surprise | 64.10% |
| Date | Price |
|---|---|
| Apr 17, 2026 | $35.60 |
| Apr 20, 2026 | $36.77 |
| Apr 21, 2026 | $38.31 |
| Apr 22, 2026 | $38.81 |
| Apr 23, 2026 | $38.53 |
| Apr 24, 2026 | $38.63 |
| Apr 27, 2026 | $38.09 |
| Apr 28, 2026 | $37.98 |
| Apr 29, 2026 | $39.55 |
| 4 days before | 8.23% |
| 4 days after | 2.65% |
| On release day | 0.260% |
| Change in period | 11.10% |
Dow Earnings Call Transcript Summary of Q1 2026
Dow Inc. reported solid 1Q26 operational performance amid significant market disruption from the Middle East conflict. Key financials: $9.8 billion in net sales, $873 million operating EBITDA, 3% sequential volume growth, and roughly $193 million of period cost savings. Management expects the Middle East conflict to drive prolonged supply constraints (potentially 6–18 months), tightening global feedstocks and support for polyethylene and other petrochemical pricing. They guided 2Q26 revenue of about $12 billion and EBITDA of about $2 billion, with pricing momentum (notably polyethylene) and higher asset utilization expected to more than offset rising feedstock costs and maintenance. Self-help programs remain a central pillar: delivering the remainder of a $1.0 billion cost program this year, Transform to Outperform targeting at least $2.0 billion of near-term EBITDA improvement (two-thirds productivity, one-third growth), and additional productivity items expected to ramp to $400 million in H2. The leadership transition was announced: Karen S. Carter will become CEO on July 1, with James R. Fitterling moving to executive chair. Financial priorities emphasize disciplined capital allocation, maintaining an investment-grade balance sheet, limited capex (at or below D&A over the cycle), returning cash to shareholders, and strong liquidity (about $14 billion total liquidity and >$4 billion cash on hand). Management views the Americas asset and feedstock position as a significant near-term advantage and expects further upside to current guidance if pricing continues to strengthen.
Sign In
Buy DOW